Relative miRNA-155-5P Expression and Level of CXCL9, CXCL10 in Patients with Cutaneous leishmaniasis before and after Pentostam Treatment

Articles in Press

Document Type : New and original researches in the field of Microbiology.

Authors

1 College of Dentistry, University of Diyala, Diyala, Iraq

2 Department of Biology, College of Science, Tikrit University, Tikrit, Iraq

Abstract

Background: MicroRNAs regulate several immune response pathways in patients with cutaneous leishmaniasis before and after treatment. Objective: The study aimed to estimate the level of immune response before and after treatment with Pentostam by assessing the levels of miRNA-155-5P, CXCL9, CXCL10.  Methodology: This study was conducted on 60 volunteers, 30 with cutaneous leishmaniasis were tested before and after treatment and 30 as a control group. ELISA was performed to determine the level of CXCL9, CXCL10, and the gene expression of miRNA-155-5P was estimated using qRT-PCR. Results: The results of the current study showed a significant increase in relative miRNA-155-5P expression in the control group with patients before treatment (p=0.001) and after treatment(p=0.001). level of CXCL9 was significantly higher in the control group compared to the patient's two groups, p=0.001 and p=0.001, respectively. The level of CXCL10 in the control group increased significantly compared to the patient's groups before treatment (p=0.001) and after treatment (p=0.004). Conclusion: We conclude from the results of the current study that miRNA-155-5P and the immune markers; CXCL9, CXCL10, could constitute a possible therapeutic target or limit the progress of leishmaniasis.

Keywords

Main Subjects

Egyptian Journal of Medical Microbiology

Articles in Press, Accepted Manuscript
Available Online from 01 January 2026

Files

Share

How to cite

Statistics